NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Fractal Analytics Shares Rise 5% After Launch of LLM Studio Platform

Fractal Analytics shares gained 5% on Tuesday following the company's announcement of the launch of LLM Studio, an enterprise platform designed to enable GenAI customization using NVIDIA NeMo and NVIDIA NIM Microservices.

The stock price advanced 4.6% to Rs 799.9 per share on the National Stock Exchange of India (NSE), marking a turnaround from two consecutive sessions of decline. The rise in share price is attributed to the company's notification to exchanges regarding the launch of LLM Studio, an enterprise platform that allows organizations to build and run language models tailored to their business needs.

LLM Studio is designed for teams seeking greater control over model governance, deployment, and management in production environments. The platform will be demonstrated at NVIDIA GTC 2026, a conference scheduled to take place from March 16 to 19, 2026 at the San Jose McEnery Convention Center in San Jose, California.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

LLM Studio enables enterprises to design, build, evaluate, and operate domain-adapted language models using open-source models powered by NVIDIA AI infrastructure and software stack. The platform consists of two modules: AutoLLM and LLMOps.

Fractal Analytics' shares had settled 6% lower on their debut day at Rs 847.15 per share on the NSE, with a 5.87% decline on February 16, 2026.

Investor Takeaway

Investors should consider the potential for Fractal Analytics to benefit from the growing demand for GenAI customization.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.